Patents by Inventor Bibiana Bielekova

Bibiana Bielekova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of multiple sclerosis
    Patent number: 7258859
    Abstract: A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of an IL-21 receptor antagonist, wherein the subject has failed to respond treatment with beta interferon, thereby treating the subject.
    Type: Grant
    Filed: June 27, 2003
    Date of Patent: August 21, 2007
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Roland Martin, Henry McFarland, Bibiana Bielekova
  • Method of treating autoimmune diseases with interferon-beta and il-2r antagonist
    Publication number: 20050249704
    Abstract: Disclosed is a method of administering an interleukin-2 receptor (IL-2R) antagonist to a subject to treat an autoimmune disease. In particular embodiments, the IL-2R antagonist is an anti-IL-2R monoclonal antibody specific for one or more chains of the IL-2R, such as the alpha-chain, for example daclizumab. In other particular embodiments the autoimmune disease is multiple sclerosis. In certain embodiments administration of interferon-beta is combined with administration of an antagonist of the IL-2R to provide significant clinical improvement in a subject with an autoimmune disease.
    Type: Application
    Filed: November 27, 2002
    Publication date: November 10, 2005
    Inventors: Roland Martin, Henry McFarland, Bibiana Bielekova, Thomas Waldmann
  • Method for the treatment of multiple sclerosis
    Publication number: 20040109859
    Abstract: A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of an IL-21 receptor antagonist, wherein the subject has failed to respond treatment with beta interferon, thereby treating the subject.
    Type: Application
    Filed: June 27, 2003
    Publication date: June 10, 2004
    Applicants: The Gov. of the USA as represented by the, Secretary of the Dept. of Health and Human Services
    Inventors: Roland Martin, Henry McFarland, Bibiana Bielekova